{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2011"],"condition":["Adenocarcinoma","Solid tumor","Primary Lymphoma of the Central Nervous System","Colorectal Adenocarcinoma, Non-small Cell Lung Cancer)","Leukemia, Lymphoid","Carcinoma, Non-Small-Cell Lung","Lymphoma, Mantle-Cell","Marginal Zone B Cell Lymphoma)","Melanoma","CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma","Any T-cell Malignancy","Lymphoma","Lymphoma, B-Cell","Neoplasms","Leukemia, Lymphocytic, Chronic, B-Cell","Ovarian cancer","Chronic Lymphocytic Leukemia","Non-small cell lung cancer","Burkett's Lymphoma","Mantle Cell Lymphoma","Ovarian Neoplasms","Solid Tumors (Metastatic Melanoma, Renal (Clear) Cell Carcinoma","Lymphoma, B-Cell, Marginal Zone","Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer"],"disease":["Adenocarcinoma","Solid Tumor","Colorectal Adenocarcinoma, Non-small Cell Lung Cancer)","Leukemia, Lymphoid","Marginal Zone B Cell Lymphoma)","Melanoma","Lymphoma, B-cell, Marginal Zone","Any T-cell Malignancy","Primary Lymphoma Of The Central Nervous System","Lymphoma","Cd27 Expressing B-cell Malignancies For Example Hodgkin's Lymphoma","Neoplasms","Solid Tumors (metastatic Melanoma, Renal (clear) Cell Carcinoma","Ovarian Cancer","Chronic Lymphocytic Leukemia","Burkett's Lymphoma","Mantle Cell Lymphoma","Non-small Cell Lung Cancer","Lymphoma, Mantle-cell","Carcinoma, Non-small-cell Lung","Ovarian Neoplasms","Lymphoma, B-cell","Leukemia, Lymphocytic, Chronic, B-cell","Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2114787"],"location":["United States"],"study_start_month":["10"],"keyword":["Renal (clear) cell carcinoma","Metastatic melanoma","CD27 expressing Solid Tumors","Burkett’s lymphoma","CD27 expressing Hematologic Malignancies","Colorectal adenocarcinoma","Hormone-refractory prostate adenocarcinoma","Antibodies, Monoclonal","Marginal zone B cell lymphoma"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers","description":"This is a study of CDX-1127, a therapy that targets the immune system and may act to promote anti-cancer effects. The study enrolls patients with hematologic cancers (certain leukemias and lymphomas), as well as patients with select types of solid tumors.","dates":{"creation":"2011-10-15"},"accession":"2114787","cross_references":{"ClinicalTrials___gov":["NCT01460134"]}}